Endoscopic ultrasound-guided biliary drainage vs percutaneous transhepatic bile duct drainage in the management of malignant obstructive jaundice

Table 1 Comparison of general data between the two subgroups

	EUS-BD (n = 33)	PTBD (n = 35)	t/χ2	P value
Age (mean SD, yr)	66.13 ± 10.04	64.36 ± 9.28	0.755	0.453
Sex, n (%)			0.391	0.532
Male	24 (72.73)	23 (65.71)
Female	9 (27.27)	12 (34.29)
BMI (mean SD, kg/m2)	23.10 ± 3.18	23.25 ± 3.23	0.195	0.846
History of smoking, n (%)			0.000	0.994
Yes	17 (51.52)	18 (51.43)
No	16 (48.48)	17 (48.57)
Cancer type, n (%)			0.066	0.967
Carcinoma of head of pancreas	15 (45.46)	17 (48.57)
Cholangiocarcinoma	10 (30.30)	10 (28.57)
Other	8 (24.24)	8 (22.86)
Disease course (mean SD, months)	6.30 ± 3.04	6.31 ± 3.17	0.015	0.988

BMI: Body mass index; EUS-BD: Endoscopic ultrasound-guided biliary drainage; PTBD: Percutaneous transhepatic puncture biliary drainage.